Compounds > fluorodopa f 18
Page last updated: 2024-08-24

fluorodopa f 18 and Restless Legs Syndrome

fluorodopa f 18 has been researched along with Restless Legs Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonini, A; Chokroverty, S; Dhawan, V; Eidelberg, D; Hening, WA; Trenkwalder, C; Walters, AS1
Brooks, DJ; Lees, AJ; Turjanski, N1
Bergman, J; Haaparanta, M; Hublin, C; Partinen, M; Rinne, JO; Ruottinen, HM; Solin, O1

Other Studies

3 other study(ies) available for fluorodopa f 18 and Restless Legs Syndrome

ArticleYear
Positron emission tomographic studies in restless legs syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Brain; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Presynaptic; Restless Legs Syndrome; Tomography, Emission-Computed

1999
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
    Neurology, 1999, Mar-23, Volume: 52, Issue:5

    Topics: Aged; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinetics; Male; Middle Aged; Raclopride; Restless Legs Syndrome; Salicylamides; Syndrome; Tomography, Emission-Computed

1999
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.
    Neurology, 2000, Jan-25, Volume: 54, Issue:2

    Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Movement Disorders; Neostriatum; Restless Legs Syndrome; Substantia Nigra; Tomography, Emission-Computed

2000